NanoString Technologies, Inc. announced a commercial leadership transition. Chad Brown, who has served as senior vice president of Sales & Marketing since June 2017, will be shifting into a part-time senior advisor role effective April 1, 2022, before fully retiring in March 2023. John D. Gerace has been named to the position of Chief Commercial Officer effective immediately.

Gerace is a veteran life science executive who brings 35 years of diverse industry experience. Over the prior four years, Gerace served as president of DiaSorin Molecular, LLC. Prior to DiaSorin, he was president and co-founder of Calabri Biosciences LLC.

From April 2015 to December 2016, he served as president and CEO of Freedom Meditech. From 2007 to 2014, he served in a variety of roles at Applied Biosystems/Life Technologies, including as vice president and general manager of the PCR Systems business unit, and later as head of the Applied Markets business unit, serving the forensic science, animal health, and food safety market segments. Prior to Life Technologies, Gerace spent 14 years at Beckman Coulter in various sales, marketing, and business development leadership roles.

He currently serves on the Board of Directors of the Iacocca Family Foundation, The UC Irvine Foundation, and University Lab Partners.